Stanford geneticist leverages Co-Scientist to accelerate drug discovery for liver fibrosis. This AI-powered approach analyzes vast biological data, identifying repurposed medications that could offer new therapeutic avenues for chronic liver disease, significantly shortening the traditional research timeline.
Opening Kapyn…